The partners’ ADC didn’t significantly extend survival in lung cancer patients who were expected to benefit the most from ...

Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet.

AstraZeneca advances ambition to improve standards of care in multiple cancer types at WCLC and ESMO 2024: Cambridge, UK Wednesday, September 4, 2024, 10:00 Hrs [IST] AstraZeneca ...

The drug candidate is administered orally in the form of a film-coated tablet ... in the UK and around the world. AstraZeneca submitted a compliant application for the clinical study to the ...

Axial Spondyloarthritis (axSpA) is a form of arthritis that mainly causes discomfort and inflammation in the spine and ...

Two operating grants valued at $100,000 per year for two years will be awarded to Canadian researchers focused on significant change in blood cancers TORONTO, Sept. 12, 2024 /CNW/ - Today marks the ...

A subretinal gene therapy was well tolerated 1 year after treatment, with no drug-related serious adverse events, in a small ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...

The success of weight-loss injections has prompted pharmaceutical companies to produce a next-generation anti-obesity pill ...